Ibd-associated microbial antigens and methods of using same
CA 2365898 C · Owner: The Regents Of The University Of California · Inventors: Braun, Jonathan; Sutton, Christopher
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides nucleic acid and amino acid sequence of the novel I-1 and I-2 polypeptides, which are associated with human inflammatory bowel disease (IBD). Methods of diagnosing and treating inflammatory bowel disease using the IBD-associated I-1 and I-2 antigens also are provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 28, 2000 and granted March 13, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.